PAOLO ANDERLINI to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications PAOLO ANDERLINI has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.029
-
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease. Transplant Cell Ther. 2021 03; 27(3):272.e1-272.e5.
Score: 0.020
-
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia. 2008 Feb; 22(2):258-64.
Score: 0.008